The future of best practiceKASTELEIN, J. J. P.Atherosclerosis. 1999, Vol 143, pp S17-S21, issn 0021-9150, SUP1Conference Paper

Bringing about Best Practice in AtherosclerosisKASTELEIN, J. J. P.Atherosclerosis. 1999, Vol 143, issn 0021-9150, 23 p., SUP1Conference Proceedings

The future of lipid-lowering therapy: the big pictureKASTELEIN, J. J. P.Netherlands journal of medicine. 2003, Vol 61, Num 5, pp 35-39, issn 0300-2977, 5 p., SUPConference Paper

Medical education : communicating best practicePOULTER, N. R.Atherosclerosis. 1999, Vol 143, pp 13-16, issn 0021-9150, SUP1Conference Paper

Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemiaKASTELEIN, J. J. P; SANKATSING, R. R.International journal of clinical practice (Esher). 2005, Vol 59, Num 12, pp 1464-1471, issn 1368-5031, 8 p.Article

Guidelines : a missed opportunityWOOD, D.Atherosclerosis. 1999, Vol 143, pp S7-S12, issn 0021-9150, SUP1Conference Paper

Best practice : Ongoing polemicsPAOLETTI, R; BELLOSTA, S.Atherosclerosis. 1999, Vol 143, pp S3-S6, issn 0021-9150, SUP1Conference Paper

Achieving lipid goals in real life : the Dutch DISCOVERY studyBOTS, A. F. E; KASTELEIN, J. J. P.International journal of clinical practice (Esher). 2005, Vol 59, Num 12, pp 1387-1394, issn 1368-5031, 8 p.Article

The gene causing familial hypoalphalipoproteinemia is not caused by a defect in the apo AI-CIII-AIV gene cluster in a Spanish familyKASTELEIN, J. J. P; HAINES, J. L; HAYDEN, M. R et al.Human genetics. 1990, Vol 84, Num 5, pp 396-400, issn 0340-6717Article

Characterization of six partial deletions in the low-density-lipoprotein (LDL) receptor gene causing familial hypercholesterolemia (FH)LANGLOIS, S; KASTELEIN, J. J. P; HAYDEN, M. R et al.American journal of human genetics. 1988, Vol 43, Num 1, pp 60-68, issn 0002-9297Article

Heterozygous familial hypercholesterolaemia in childhood: Cardiovascular risk preventionVAN DER GRAAF, A; KASTELEIN, J. J. P; WIEGMAN, A et al.Journal of inherited metabolic disease. 2009, Vol 32, Num 6, pp 699-705, issn 0141-8955, 7 p.Article

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: A large cross-sectional study in The NetherlandsPIJLMAN, A. H; HUIJGEN, R; VERHAGEN, S. N et al.Atherosclerosis. 2010, Vol 209, Num 1, pp 189-194, issn 0021-9150, 6 p.Article

A boy with autosomal recessive hypercholesterolaemiaRODENBURG, J; WIEGMAN, A; VISSERS, M. N et al.Netherlands journal of medicine. 2004, Vol 62, Num 3, pp 89-93, issn 0300-2977, 5 p.Article

ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levelsZWARTSA, K. Y; CLEE, S. M; KASTELEIN, J. J. P et al.Clinical genetics. 2002, Vol 61, Num 2, pp 115-125, issn 0009-9163Article

Results from a family and DNA based active identification programme for familial hypercholesterolaemiaTEN ASBROEK, A. H. A; MARANG-VAN DE MHEEN, P. J; DEFESCHE, J. C et al.Journal of epidemiology and community health (1979). 2001, Vol 55, Num 7, pp 500-502, issn 0143-005XArticle

A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease : the Framingham Offspring StudyGAGNE, S. E; LARSON, M. G; PIMSTONE, S. N et al.Clinical genetics. 1999, Vol 55, Num 6, pp 450-454, issn 0009-9163Article

A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaWITTEKOEK, M. E; MOLL, E; PIMSTONE, S. N et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 11, pp 2708-2713, issn 1079-5642Article

Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patientsVON ECKARDSTEIN, A; YADONG HUANG; KASTELEIN, J. J. P et al.Atherosclerosis. 1998, Vol 138, Num 1, pp 25-34, issn 0021-9150Article

The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosisKUIVENHOVEN, J. A; JUKEMA, J. W; ZWINDERMAN, A. H et al.The New England journal of medicine. 1998, Vol 338, Num 2, pp 86-93, issn 0028-4793Article

Ser_447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic malesKUIVENHOVEN, J. A; GROENEMEYER, B. E; BOER, J. M. A et al.Arteriosclerosis, thrombosis, and vascular biology. 1997, Vol 17, Num 3, pp 595-599, issn 1079-5642Article

Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemiaBREDIE, S. J. H; WESTERVELD, H. T; KNIPSCHEER, H. C et al.Netherlands journal of medicine. 1996, Vol 49, Num 2, pp 59-67, issn 0300-2977Article

The lipoprotein lipase (Asn291→Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemiaHOFFER, M. J. V; BREDIE, S. J. H; BOOMSMA, D. I et al.Atherosclerosis. 1996, Vol 119, Num 2, pp 159-167, issn 0021-9150Article

A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemiaREYMER, P. W. A; GROENEMEYER, B. E; HAYDEN, M. R et al.Human molecular genetics (Print). 1995, Vol 4, Num 9, pp 1543-1549, issn 0964-6906Article

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizabilityBREDIE, S. J. H; DE BRUIN, T. W. A; DEMACKER, P. N. M et al.The American journal of cardiology. 1995, Vol 75, Num 5, pp 348-353, issn 0002-9149Article

Screening for familial defective apolipoprotein B-100 with improved U937 monocyte proliferation assayVAN DEN BROEK, A. J. C. M; HOLLAAR, L; SCHAEFER, H. I. M. B et al.Clinical chemistry (Baltimore, Md.). 1994, Vol 40, Num 3, pp 395-399, issn 0009-9147Article